News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
243,504 Results
Type
Article (23057)
Company Profile (11)
Press Release (220436)
Multimedia
Podcasts (48)
Webinars (6)
Section
Business (64869)
Career Advice (1058)
Deals (11326)
Drug Delivery (53)
Drug Development (44326)
Employer Resources (70)
FDA (6946)
Job Trends (5914)
News (126162)
Policy (12184)
Tag
Academia (1314)
Accelerated approval (20)
Adcomms (22)
Allergies (73)
Alliances (16361)
ALS (87)
Alzheimer's disease (876)
Antibody-drug conjugate (ADC) (169)
Approvals (7040)
Artificial intelligence (168)
Autoimmune disease (80)
Automation (9)
Bankruptcy (90)
Best Places to Work (4711)
BIOSECURE Act (9)
Biosimilars (95)
Biotechnology (13)
Bladder cancer (68)
Brain cancer (35)
Breast cancer (287)
Cancer (2268)
Cardiovascular disease (214)
Career advice (899)
Career pathing (26)
CAR-T (153)
CDC (27)
Celiac Disease (1)
Cell therapy (381)
Cervical cancer (21)
Clinical research (38342)
Collaboration (640)
Company closure (4)
Compensation (331)
Complete response letters (27)
COVID-19 (1718)
CRISPR (41)
C-suite (323)
Cystic fibrosis (85)
Data (3292)
Denatured (4)
Depression (84)
Diabetes (233)
Diagnostics (2059)
Digital health (8)
Diversity (4)
Diversity, equity & inclusion (21)
Drug discovery (86)
Drug pricing (86)
Drug shortages (10)
Duchenne muscular dystrophy (115)
Earnings (29430)
Editorial (41)
Employer branding (8)
Employer resources (67)
Events (35144)
Executive appointments (347)
FDA (8208)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (9)
Funding (525)
Gene editing (90)
Generative AI (18)
Gene therapy (334)
GLP-1 (528)
Government (2182)
Grass and pollen (4)
Guidances (183)
Healthcare (6984)
HIV (40)
Huntington's disease (26)
IgA nephropathy (49)
Immunology and inflammation (160)
Immuno-oncology (26)
Indications (48)
Infectious disease (1845)
Inflammatory bowel disease (93)
Inflation Reduction Act (7)
Influenza (46)
Intellectual property (91)
Interviews (186)
IPO (5069)
IRA (26)
Job creations (1346)
Job search strategy (748)
JPM (29)
Kidney cancer (9)
Labor market (46)
Layoffs (334)
Leadership (15)
Legal (2430)
Liver cancer (41)
Longevity (2)
Lung cancer (344)
Lymphoma (242)
Machine learning (11)
Management (25)
Manufacturing (280)
MASH (93)
Medical device (4285)
Medtech (4300)
Mergers & acquisitions (6615)
Metabolic disorders (648)
Multiple sclerosis (77)
NASH (14)
Neurodegenerative disease (148)
Neuropsychiatric disorders (50)
Neuroscience (1480)
Neurotech (1)
NextGen: Class of 2026 (2346)
Non-profit (1729)
Now hiring (22)
Obesity (307)
Opinion (170)
Ovarian cancer (79)
Pain (107)
Pancreatic cancer (100)
Parkinson's disease (128)
Partnered (14)
Patents (161)
Patient recruitment (200)
Peanut (23)
People (17194)
Pharmaceutical (6)
Pharmacy benefit managers (9)
Phase 1 (10970)
Phase 2 (16838)
Phase 3 (14164)
Pipeline (2443)
Policy (146)
Postmarket research (1328)
Preclinical (3776)
Press Release (17)
Prostate cancer (100)
Psychedelics (32)
Radiopharmaceuticals (120)
Rare diseases (450)
Real estate (1808)
Recruiting (31)
Regulatory (9596)
Reports (9)
Research institute (1134)
Resumes & cover letters (158)
Rett syndrome (7)
RNA editing (6)
RSV (36)
Schizophrenia (95)
Series A (88)
Series B (65)
Service/supplier (1)
Sickle cell disease (53)
Special edition (14)
Spinal muscular atrophy (134)
Sponsored (20)
Startups (1432)
Stomach cancer (8)
Supply chain (29)
Tariffs (44)
The Weekly (43)
Vaccines (596)
Venture capital (56)
Weight loss (211)
Women's health (23)
Worklife (14)
Date
Last 7 days (194)
Last 30 days (753)
Last 365 days (11915)
2026 (1019)
2025 (12055)
2024 (13508)
2023 (15473)
2022 (19075)
2021 (20569)
2020 (19263)
2019 (16924)
2018 (13319)
2017 (12804)
2016 (11928)
2015 (13692)
2014 (9449)
2013 (7188)
2012 (7945)
2011 (8396)
2010 (7110)
Location
Africa (385)
Alabama (21)
Alaska (3)
Arizona (77)
Asia (16106)
Australia (2783)
California (4069)
Canada (1115)
China (477)
Colorado (186)
Connecticut (199)
Delaware (134)
Europe (37220)
Florida (602)
Georgia (155)
Hawaii (1)
Idaho (14)
Illinois (281)
India (15)
Indiana (178)
Iowa (5)
Japan (214)
Kansas (53)
Kentucky (6)
Louisiana (5)
Maine (18)
Maryland (422)
Massachusetts (3133)
Michigan (110)
Minnesota (199)
Mississippi (3)
Missouri (30)
Montana (12)
Nebraska (12)
Nevada (40)
New Hampshire (21)
New Jersey (1364)
New Mexico (7)
New York (1131)
North Carolina (533)
North Dakota (2)
Northern California (2086)
Ohio (100)
Oklahoma (7)
Oregon (12)
Pennsylvania (856)
Puerto Rico (9)
Rhode Island (13)
South America (449)
South Carolina (18)
Southern California (1549)
Tennessee (45)
Texas (524)
United States (14694)
Utah (96)
Virginia (82)
Washington D.C. (27)
Washington State (378)
West Virginia (2)
Wisconsin (23)
243,504 Results for "two pore guys".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alcami Promotes Guy Kubi to Chief Operating Officer
January 29, 2026
·
1 min read
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
Layoffs
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs
Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s disease continue to advance.
December 18, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Life-Threatening Liver Toxicity Triggers FDA Freeze on Two Intellia Gene Therapy Studies
The clinical hold comes days after Intellia voluntarily paused enrollment and dosing in the same two studies.
October 30, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
How the American Pharma Industry Became the ‘Bad Guys’
Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry hold the same respect as steelworkers or other all-American pursuits?
August 20, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Aclaris Therapeutics to Participate in Two February Healthcare Conferences
February 4, 2026
·
1 min read
Press Releases
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences in March 2026
February 6, 2026
·
2 min read
Press Releases
Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
February 3, 2026
·
4 min read
Press Releases
Sagimet Biosciences Announces Participation in Two Upcoming February 2026 Investor Conferences
February 5, 2026
·
1 min read
Press Releases
Neogen® Announces Two Senior Leadership Appointments
January 5, 2026
·
1 min read
1 of 24,351
Next
